Review The SDS Document
DOWNLOADProduct Details
Formula
C9H24NNaO8P2
MW
359.23
Purity
>95%
Solubility (DMSO Mg/MI)
90
Mode Of Action
inhibitor
Drug Status
Approved
Target Name
Geranyltranstransferase (FDPS)
Research Area
ENDOCRINOLOGY
Research Area Sub Group
Bone Density Conservation
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Transferase
Bio Chemical Notes
Ibandronate is used in treatment of osteoporosis in postmenopausal women. Inhibits farnesyl pyrophosphate (FPP) synthase. Action on bone tissue is due to its affinity for hydroxyapatite. Ref: Drugs. 1999; 57 (1), 101-108 (8).